Biological and quantitative-SAR evaluations, and docking studies of (E)-N'-benzylidenebenzohydrazide analogues as potential antibacterial agents

dc.contributor.authorAlam, Mohammad Sayed
dc.contributor.authorJebin, Sefat
dc.contributor.authorRahman, M. Mostafizur
dc.contributor.authorBari, Md. Latiful
dc.contributor.authorLee, Dong-Ung
dc.date.accessioned2016-11-23T12:31:05Z
dc.date.available2016-11-23T12:31:05Z
dc.date.issued2016-06-17
dc.description.abstractA series of 15 (E)-N'-benzylidenebenzohydrazide analogues were evaluated for their antimicrobial activities against eleven pathogenic and food-borne microbes, namely, S. aureus (G+), L. monocytogenes (G+), B. subtilis (G+), K. pneumonia (G-), C. sakazakii (G-), C. freundii (G-), S. enterica (G-), S. enteritidis (G-), E. coli (G-), Y. pestis (G-), and P. aeruginosa (G-). Most of the compounds exhibited selective activity against some Gram-negative bacterial strains. Of the compounds tested (3a-o), 3b and 3g were most active against C. freundii (MIC = ~19 µg mL-1). Whereas, compounds 3d, 3i, 3k and 3n exhibited MIC values ranging from 37.5 to 75 µg mL-1 against C. freundii, and compounds 3e, 3l and 3n had MIC values of ~75 µg mL-1 against K. pneumonia. Quantitative structure-antibacterial activity relationships were studied using physicochemical parameters and a good correlation was found between calculated octanol-water partition coefficients (clogP; a lipophilic parameter) and antibacterial activities. In silico screening was also performed by docking high (3b and 3g) and low (3n) activity compounds on the active site of E. coli FabH receptor, which is an important therapeutic target. The findings of these in silico screening studies provide a theoretical basis for the design and synthesis of novel benzylidenebenzohydrazide analogues that inhibit bacterial FabH.en
dc.identifier.doi10.17179/excli2016-388
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/35383
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-17424
dc.language.isoen
dc.relation.ispartofseriesEXCLI Journal;Vol. 15, 2016
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectHydrazone Schiff baseen
dc.subjectantimicrobial activityen
dc.subjectphysicochemical propertiesen
dc.subjectdocking studyen
dc.subject.ddc610
dc.titleBiological and quantitative-SAR evaluations, and docking studies of (E)-N'-benzylidenebenzohydrazide analogues as potential antibacterial agentsen
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Lee_17062016_proof.pdf
Size:
1.24 MB
Format:
Adobe Portable Document Format
Description:
DNB
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.12 KB
Format:
Item-specific license agreed upon to submission
Description: